This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This STARD13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 544-573 amino acids from the Central region of human STARD13.
STARD13
Reactivity: Human
ELISA, WB
Host: Rabbit
Polyclonal
FITC
Application Notes
For WB starting dilution is: 1:1000
Restrictions
For Research Use only
Format
Liquid
Concentration
0.32 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
STARD13
(StAR-Related Lipid Transfer (START) Domain Containing 13 (STARD13))
ARHGAP37 antibody, DLC2 antibody, GT650 antibody, LINC00464 antibody, RGD1564816 antibody, StAR related lipid transfer domain containing 13 antibody, StAR-related lipid transfer (START) domain containing 13 antibody, StAR-related lipid transfer domain containing 13 antibody, STARD13 antibody, Stard13 antibody
Background
This gene encodes a protein that contains a sterile alpha motif domain in the N-terminus, an ATP/GTP-binding motif, a GTPase-activating protein domain, and a STAR-related lipid transfer domain in the C-terminus. The gene is located in a region of chromosome 13 that has loss of heterozygosity in hepatic cancer. At least three alternatively spliced transcript variants have been described for this gene.